Evan L. Wasoff - Apr 20, 2022 Form 4 Insider Report for NEXIEN BIOPHARMA, INC. (NXEN)

Signature
Evan L. Wasoff
Stock symbol
NXEN
Transactions as of
Apr 20, 2022
Transactions value $
$0
Form type
4
Date filed
9/14/2022, 05:42 PM
Previous filing
Jan 31, 2022
Next filing
Oct 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NXEN Common stock Award +250K +9.09% 3M Apr 20, 2022 Direct F1
transaction NXEN Common Stock Award +250K +8.33% 3.25M Jul 27, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NXEN Options to purchase common stock (right to buy) 1.5M Apr 20, 2022 common stock 1.5M $0.08 Direct
holding NXEN Options to purchase common stock (right to buy) 420K Apr 20, 2022 common stock 420K $0.54 Direct
holding NXEN Options to purchase common stock (right to buy) 200K Apr 20, 2022 common stock 200K $0.66 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Issued in lieu of compensation for services.